ACP
Acuta Capital Partners’s Sarepta Therapeutics SRPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-27,500
| Closed | -$4.35M | – | 47 |
|
|
2024
Q2 | $4.35M | Sell |
27,500
-36,662
| -57% | -$5.79M | 3.66% | 11 |
|
|
2024
Q1 | $8.31M | Sell |
64,162
-6,438
| -9% | -$833K | 5.4% | 6 |
|
|
2023
Q4 | $6.81M | Buy |
70,600
+55,100
| +355% | +$5.31M | 3.83% | 7 |
|
|
2023
Q3 | $1.88M | Buy |
+15,500
| New | +$1.88M | 1.26% | 25 |
|
|
2023
Q2 | – | Sell |
-32,770
| Closed | -$4.52M | – | 41 |
|
|
2023
Q1 | $4.52M | Sell |
32,770
-34,730
| -51% | -$4.79M | 3.33% | 12 |
|
|
2022
Q4 | $8.75M | Buy |
67,500
+26,000
| +63% | +$3.37M | 5.38% | 6 |
|
|
2022
Q3 | $4.59M | Buy |
+41,500
| New | +$4.59M | 1.98% | 17 |
|
|
2018
Q3 | – | Sell |
-60,000
| Closed | -$7.93M | – | 39 |
|
|
2018
Q2 | $7.93M | Buy |
+60,000
| New | +$7.93M | 1.41% | 16 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 55 |
|
|
2016
Q4 | – | Sell |
-50,000
| Closed | -$3.07M | – | 53 |
|
|
2016
Q3 | $3.07M | Sell |
50,000
-80,000
| -62% | -$4.91M | 1.15% | 25 |
|
|
2016
Q2 | $2.48M | Buy |
+130,000
| New | +$2.48M | 1.19% | 23 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 48 |
|
|
2015
Q4 | – | Sell |
-31,744
| Closed | -$1.02M | – | 61 |
|
|
2015
Q3 | $1.02M | Buy |
+31,744
| New | +$1.02M | 0.59% | 40 |
|